Top

Published in:

Open Access 01-12-2012 | Case report

Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report

Authors: Barbara Kaczorowska-Hac, Agnieszka Matheisel, Lucyna Maciejka-Kapuscinska, Jakub Wisniewski, Anna Alska, Elzbieta Adamkiewicz-Drozynska, Anna Balcerska, Iwona Reszczynska

Published in: Journal of Medical Case Reports | Issue 1/2012

Abstract

Introduction

Valproic acid is a commonly used anti-epileptic drug. Hematological toxicities are among the occasionally observed adverse effects of this medication.

Case presentation

We present the case of a 13-year-old Caucasian boy who demonstrated mild anemia 12 months after the introduction of valproic acid therapy. A bone marrow biopsy revealed maturation arrest of proerythroblasts.

Conclusion

Prompt diagnosis and valproic acid discontinuation resulted in the patient’s recovery.

Available only for authorised users

The T, Kolla R, Dawkins F, Trouth AJ: Pure red cell aplasia after 13 years of sodium valproate, and bone marrow suppression after 17 years of carbamazepine. PLoS Med. 2004, 1: e51-10.1371/journal.pmed.0010051.CrossRefPubMedPubMedCentral

Zaccara G, Franciotta D, Perucca E: Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia. 2007, 48: 1223-1244. 10.1111/j.1528-1167.2007.01041.x.CrossRefPubMed

Acharya S, Bussel JB: Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol. 2000, 22: 62-65. 10.1097/00043426-200001000-00012.CrossRefPubMed

Handoko KB, Souverein PC, van Staa TP, Meyboom RH, Leufkens HG, Egberts TC, van den Bemt PM: Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia. 2006, 47: 1232-1236. 10.1111/j.1528-1167.2006.00596.x.CrossRefPubMed

Kanada J, Chonabayashi K, Watanabe M, Arima N, Tsudo M: Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia] [in Japanese. Rinsho Ketsueki. 2005, 46: 1114-1117.

Farkas V, Szabó M, Rényi I, Kohlhéb O, Benninger C: Temporary pure red-cell aplasia during valproate monotherapy: clinical observations and spectral electroencephalographic aspects. J Child Neurol. 2000, 15: 485-487. 10.1177/088307380001500713.CrossRefPubMed

Nasreddine W, Beydoun A: Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia. 2008, 49: 438-445. 10.1111/j.1528-1167.2007.01429.x.CrossRefPubMed

Rahman A, Mican LM, Fischer C, Campbell AH: Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. Ann Pharmacother. 2009, 43: 822-830. 10.1345/aph.1L617.CrossRefPubMed

Klimaszyk D, Łukasik-Głebocka M: Pancytopenia in the course of acute valproic acid poisoning: case report [in Polish]. Przegl Lek. 2011, 68: 539-542.PubMed

10.

Hemingway C, Leary M, Riordan G, Schlegal G, Walker K: The effect of carbamazepine and sodium valproate on the blood and serum values of children from a Third-World environment. J Child Neurol. 1999, 14: 751-753. 10.1177/088307389901401114.CrossRefPubMed

11.

Antoniou T, Gough K, Yoong D, Arbess G: Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid. Clin Infect Dis. 2004, 38: e38-e40. 10.1086/381760.CrossRefPubMed

12.

Bartakke S, Abdelhaleem M, Carcao M: Valproate-induced pure red cell aplasia and megakaryocyte dysplasia. Br J Haematol. 2008, 141: 133-10.1111/j.1365-2141.2008.06979.x.CrossRefPubMed

13.

Chateauvieux S, Eifes S, Morceau F, Grigorakaki C, Schnekenburger M, Henry E, Dicato M, Diederich M: Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway. Biochem Pharmacol. 2011, 81: 498-509. 10.1016/j.bcp.2010.11.011.CrossRefPubMed

Title: Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report
Authors: Barbara Kaczorowska-Hac
Agnieszka Matheisel
Lucyna Maciejka-Kapuscinska
Jakub Wisniewski
Anna Alska
Elzbieta Adamkiewicz-Drozynska
Anna Balcerska
Iwona Reszczynska
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: Journal of Medical Case Reports / Issue 1/2012
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/1752-1947-6-239

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report

Abstract

Introduction

Case presentation

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2012

Spontaneous Incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report

Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report

Eosinophilic panniculitis presenting with Kaposi’s sarcoma-like plaques in a patient who is human immunodeficiency virus positive: a case report

Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report

Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report

Unusual cardiac outcomes of bacteremia due to Staphylococcus aureus infection: a case report